Published in Comp Biochem Physiol B Biochem Mol Biol on July 01, 1996
Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. Mol Pathol (1999) 1.06
Cystatin E/M suppresses legumain activity and invasion of human melanoma. BMC Cancer (2010) 0.97
Cystatin C in Alzheimer's disease. Front Mol Neurosci (2012) 0.94
Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis. Ann Rheum Dis (2004) 0.87
Cystatin C uptake in the eye. Graefes Arch Clin Exp Ophthalmol (2004) 0.84
Cross-interactions between the Alzheimer Disease Amyloid-β Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis. J Biol Chem (2016) 0.79
Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells. Mol Pathol (1998) 0.77
Serum cystatin C is associated with large cerebral artery stenosis in acute ischemic stroke. Oncotarget (2017) 0.77
Discordance in cathepsin B and cystatin C expressions in bronchoalveolar fluids between murine bleomycin-induced fibrosis and human idiopathic fibrosis. Respir Res (2016) 0.75
Cystatin C in aging and in Alzheimer's disease. Ageing Res Rev (2016) 0.75
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A (1993) 10.82
Areawide suppression of European corn borer with Bt maize reaps savings to non-Bt maize growers. Science (2010) 4.28
Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development (1995) 4.05
Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J (2001) 3.24
Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc Natl Acad Sci U S A (1996) 3.07
Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat Struct Biol (2001) 2.86
Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J Biol Chem (2000) 2.62
Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem (1994) 2.62
Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest (2004) 2.48
Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest (1999) 2.27
Developmental regulation of human globin genes. Annu Rev Biochem (1985) 2.16
Standardization of Cystatin C: development of primary and secondary reference preparations. Scand J Clin Lab Invest Suppl (2008) 2.11
Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor. Nature (1989) 2.08
Structure and expression of the human cystatin C gene. Biochem J (1990) 2.07
Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J Biol Chem (1986) 2.03
Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest (1999) 2.03
Immune dysregulation in TGF-beta 1-deficient mice. J Immunol (1994) 2.00
Low level exposure to cadmium and early kidney damage: the OSCAR study. Occup Environ Med (2000) 1.96
Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells. Proc Natl Acad Sci U S A (1989) 1.84
The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest (1985) 1.81
Postterm pregnancy: putting the merits of a policy of induction of labor into perspective. Birth (1996) 1.79
Why Britain can't afford informed consent. Hastings Cent Rep (1985) 1.73
Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatin. Biochem J (1986) 1.71
Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest (1996) 1.70
Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand (1985) 1.65
Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery. Br J Anaesth (2011) 1.65
Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype. Proc Natl Acad Sci U S A (1993) 1.64
Transforming growth factor-beta 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am J Pathol (1993) 1.64
Identification of the probable inhibitory reactive sites of the cysteine proteinase inhibitors human cystatin C and chicken cystatin. J Biol Chem (1987) 1.61
Three cases of neonatal meningitis caused by Enterobacter sakazakii in powdered milk. J Clin Microbiol (1989) 1.60
Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur J Haematol (1989) 1.57
The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem Biophys Res Commun (1984) 1.56
Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. Proc Natl Acad Sci U S A (1982) 1.55
Spinal subdural haematoma in a parturient after attempted epidural anaesthesia. Can J Anaesth (1993) 1.54
Aromatic DNA adducts in foundry workers in relation to exposure, life style and CYP1A1 and glutathione transferase M1 genotype. Carcinogenesis (1997) 1.53
Low-level cadmium exposure and osteoporosis. J Bone Miner Res (2000) 1.53
Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. J Biol Chem (1999) 1.52
Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse. Blood (1996) 1.51
Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacol Toxicol (1997) 1.50
FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor. Neuron (2000) 1.50
Arterial anatomy of the upper extremity. Acta Radiol Diagn (Stockh) (1982) 1.50
Renal impairment after hip or knee arthroplasty. Urinary excretion of protein markers studied in 59 patients. Acta Orthop Scand (1997) 1.49
Efficient production of native, biologically active human cystatin C by Escherichia coli. FEBS Lett (1988) 1.47
Promoter sequences required for function of the human gamma globin gene in erythroid cells. EMBO J (1986) 1.47
Breach of confidence: anonymised information. R. v. Department of Health ex parte Source Informatics Ltd. Med Law Rev (2000) 1.43
A tumor necrosis factor binding protein is present in human biological fluids. Eur J Haematol (1988) 1.43
Functional effects of the inhibition of the cysteine protease activity of the major house dust mite allergen Der p 1 by a novel peptide-based inhibitor. Clin Exp Allergy (2000) 1.42
Impact of implant interdependency when evaluating success rates: a statistical analysis of multicenter results. Int J Prosthodont (1999) 1.42
Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc Natl Acad Sci U S A (1993) 1.40
A novel mutation in the beta-protein coding region of the amyloid beta-protein precursor (APP) gene. Hum Genet (1992) 1.39
Identification, characterization and localization of chagasin, a tight-binding cysteine protease inhibitor in Trypanosoma cruzi. J Cell Sci (2001) 1.39
Carriage of respiratory tract pathogens and molecular epidemiology of Streptococcus pneumoniae colonization in healthy children attending day care centers in Lisbon, Portugal. Microb Drug Resist (1999) 1.38
Lentivirus vector gene expression during ES cell-derived hematopoietic development in vitro. J Virol (2000) 1.38
Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma. Genes Dev (1994) 1.37
Water sorption and solubility of dental composites and identification of monomers released in an aqueous environment. J Oral Rehabil (2001) 1.37
Retroviral-mediated transfer of genomic globin genes leads to regulated production of RNA and protein. Proc Natl Acad Sci U S A (1987) 1.34
Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C. FEBS Lett (1987) 1.34
Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. J Clin Invest (1987) 1.33
Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases. Biochem J (1986) 1.32
Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet (1988) 1.31
Rapid cloning of rearranged immunoglobulin genes from human hybridoma cells using mixed primers and the polymerase chain reaction. Biochem Biophys Res Commun (1989) 1.26
Analysis of the RPGR gene in 11 pedigrees with the retinitis pigmentosa type 3 genotype: paucity of mutations in the coding region but splice defects in two families. Am J Hum Genet (1997) 1.25
Protein D, an immunoglobulin D-binding protein of Haemophilus influenzae: cloning, nucleotide sequence, and expression in Escherichia coli. Infect Immun (1991) 1.25
Cystatin C, a human proteinase inhibitor, blocks replication of herpes simplex virus. J Virol (1990) 1.25
New markers for the determination of GFR: iohexol clearance and cystatin C serum concentration. Kidney Int Suppl (1994) 1.25
Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation. Hum Gene Ther (1998) 1.25
Cytokine-induced Src homology 2 protein (CIS) promotes T cell receptor-mediated proliferation and prolongs survival of activated T cells. J Exp Med (2000) 1.24
Reference intervals for the glomerular filtration rate and cell-proliferation markers: serum cystatin C and serum beta 2-microglobulin/cystatin C-ratio. Scand J Clin Lab Invest (1997) 1.24
Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice. Proc Natl Acad Sci U S A (1994) 1.23
Human cystatin C. role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase. Biochem J (1991) 1.22
Protein D of Haemophilus influenzae. A novel bacterial surface protein with affinity for human IgD. J Immunol (1990) 1.22
Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders. Am J Pathol (1995) 1.19
High levels of human glucocerebrosidase activity in macrophages of long-term reconstituted mice after retroviral infection of hematopoietic stem cells. Blood (1992) 1.17
Influence of pH and storage time on the sorption and solubility behaviour of three composite resin materials. J Dent (2001) 1.14
Abnormal metabolism of gamma-trace alkaline microprotein. The basic defect in hereditary cerebral hemorrhage with amyloidosis. N Engl J Med (1984) 1.13
Human protein HC and its IgA complex are inhibitors of neutrophil chemotaxis. Proc Natl Acad Sci U S A (1986) 1.13
Stable gene transfer and tissue-specific expression of a human globin gene using adenoviral vectors. EMBO J (1986) 1.13
DNA sequences specific for Caucasian G3m(b) and (g) allotypes: allotyping at the genomic level. Immunogenetics (1994) 1.13
Transfer of genes into hematopoietic cells using recombinant DNA viruses. Proc Natl Acad Sci U S A (1985) 1.12
Structural basis for the biological specificity of cystatin C. Identification of leucine 9 in the N-terminal binding region as a selectivity-conferring residue in the inhibition of mammalian cysteine peptidases. J Biol Chem (1995) 1.11
Survival rate and failure characteristics for two post designs. J Prosthet Dent (1995) 1.10
Urine excretion of protein HC in proteinuric glomerular diseases correlates to urine IgG but not to albuminuria. Kidney Int (2001) 1.09
Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy. Scand J Clin Lab Invest (2002) 1.08
Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells. Scand J Clin Lab Invest (1995) 1.08
The role of Smad signaling in hematopoiesis and translational hematology. Leukemia (2011) 1.08
Analysis of proteinuria: reference limits for urine excretion of albumin, protein HC, immunoglobulin G, kappa- and lambda-immunoreactivity, orosomucoid and alpha 1-antitrypsin. Scand J Clin Lab Invest (1996) 1.08
Isolation and some properties of an IgG Fc-binding protein from group A streptococci type 15. Int Arch Allergy Appl Immunol (1982) 1.08
Uterine incision and maternal blood loss in preterm caesarean section. Arch Gynecol Obstet (1993) 1.07
Stability of albumin, protein HC, immunoglobulin G, kappa- and lambda-chain immunoreactivity, orosomucoid and alpha 1-antitrypsin in urine stored at various conditions. Scand J Clin Lab Invest (1994) 1.07
Cystatin C reduces the in vitro formation of soluble Abeta1-42 oligomers and protofibrils. Scand J Clin Lab Invest (2007) 1.07